2.23 Million-Person Study Finds Pneumococcal Vaccines Increase Risk of Pneumonia and Death
October 22nd, 2025Via: Focal Points:
…a landmark population-based study published in BMC Infectious Diseases has shattered the rationale for current pneumococcal conjugate vaccine (PCV) recommendations. Analyzing outcomes among 2,234,003 adults aged 50 and older in Catalonia, Spain, the authors found that recipients of both PCV13 and PPSV23 were significantly more likely to be hospitalized for pneumonia and more likely to die from pneumonia-related causes compared to their unvaccinated counterparts—even after adjusting for age, sex, comorbidities, and influenza vaccination status.
…
Even in those for whom vaccination is most strongly recommended—elderly (?65 years), immunocompromised, or those with chronic heart, lung, or metabolic disease—no protective effect was observed.

Birx’d:
http://www.x.com/SenseReceptor/status/1981116403701928334